28077790 |
FLT3 activating mutations display differential sensitivity to multiple tyrosine kinase inhibitors
Levis, M,
Nguyen, B,
Williams, AB,
Small, D,
Brown, P,
Li, L,
Young, DJ,
Ma, H
|
Oncotarget |
2017 |
26999641 |
Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
Vallon-Christersson, J,
Puissant, A,
Rönnstrand, L,
Borg, A,
Cordero, E,
Levander, F,
Stegmaier, K,
Kazi, JU,
Hemann, MT,
Haraldsson, K,
Pietras, K,
Sun, J,
Kabir, NN,
Ramos, A,
Macaulay, L,
Lindblad, O
|
Oncogene |
2016 |